EMvision Medical Devices Ltd. (AU:EMV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
EMVision Medical Devices Ltd has successfully completed Stage 3 recruitment for their multi-site clinical trial, focusing on hemorrhagic and ischemic stroke patients to enhance their AI diagnostic algorithms. The company is actively engaging with the FDA for a pre-submission review and preparing for a validation trial crucial for market entry. With the clinical trial data under verification, results are expected in the second half of 2024, marking a significant milestone for EMVision’s innovative neurodiagnostic product.
For further insights into AU:EMV stock, check out TipRanks’ Stock Analysis page.